Form 4: CVS Director Finucane Boosts Stake with Stock & DSUs

CVS Health Director Anne Finucane acquired additional common stock and deferred stock units on November 20, 2025, as part of her routine compensation package.

Summary

• Anne A. Finucane, a Director of CVS Health Corp. (CVS), reported changes in her beneficial ownership.
• On November 20, 2025, Ms. Finucane acquired 591 shares of CVS common stock at a price of $76.04 per share.
• This common stock was issued as payment for a semi-annual retainer, pursuant to the Issuer's 2017 Incentive Compensation Plan.
• Additionally, on the same date, Ms. Finucane acquired 1,775.3814 Deferred Stock Units (DSUs) at a value of $76.04 per unit.
• These DSUs were issued for the deferral of a semi-annual retainer, in connection with the Issuer's non-employee director compensation policy and the 2017 Incentive Compensation Plan.
• Each DSU is convertible into one share of common stock and will be issued in the future as elected by Ms. Finucane.
• Following these transactions, Ms. Finucane directly beneficially owns 591 shares of common stock and 16,530.0615 Deferred Stock Units.

Sentiment

Score: 7

Explanation: The filing indicates a director's acquisition of company stock and deferred stock units as part of routine compensation, which generally signals alignment of interests with shareholders and confidence in the company's value, without indicating any new material operational or financial developments.

Positives

• Director Anne A. Finucane increased her direct beneficial ownership in CVS Health Corp. through the acquisition of common stock and deferred stock units.
• The transactions, being part of a compensation plan, align the director's financial interests more closely with those of the company's shareholders.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Acquisition of common stock and deferred stock units by Director Anne A. Finucane from CVS Health Corp. as part of her semi-annual retainer, consistent with the company's 2017 Incentive Compensation Plan and non-employee director compensation policy.

Stakeholder Impact

• Shareholders: The director's increased beneficial ownership aligns her interests with those of the shareholders, potentially fostering greater confidence in management's commitment to long-term value.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction where a director received common stock and deferred stock units as part of her compensation. While it indicates alignment of interests, it does not provide new fundamental information to warrant a change in investment recommendation based solely on this filing.

Keywords

CVS Health, CVS, Form 4, Insider Transaction, Beneficial Ownership, Director Compensation, Stock Acquisition, Deferred Stock Units